Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma

Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma

Background We conducted a pilot phase II study to evaluate the efficacy and safety of S-1 as a first-line, S-1 plus cisplatin as a second-line, and weekly paclitaxel as a third-line therapy for advanced gastric cancer. Patients and Methods Between 2002 and 2005, 19 patients were enrolled in this stu...

Full description

Bibliographic Details
Main Authors: Yasushi Rino M.D., Norio Yukawa, Nobuyuki Wada, Makoto Suzuki, Hitoshi Murakami, Takanobu Yamada, Hirotaka Nakayama, Naoto Yamamoto, Tsutomu Sato, Roppei Yamada, Takashi Ohshima, Munetaka Masuda, Toshio Imada
Format: Article
Language:English
Published: SAGE Publishing 2008-01-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.4137/CMO.S610

Internet

https://doi.org/10.4137/CMO.S610

Similar Items